PCPs Cautious with GLP-1 Prescriptions Despite increasing patient demand, PCPs remain generally cautious when prescribing GLP-1 medications
Your questions answered Commonquestions Every patient's journey starts with good information
J., Yoon S
Most GLP-1 solutions should be clear and colourless to slightly yellow, but some products (like exenatide prolonged-release) are suspensions and appear cloudy by design
Peripheral Neuropathy ALC has been studied for its potential to reduce symptoms of peripheral neuropathy, such as pain, numbness, and tingling, particularly in diabetic patients
This effect is particularly important for individuals with obesity, as sustained weight loss is a key factor in mitigating the risks associated with excessive weight, such as cardiovascular disease, type 2 diabetes, and metabolic syndrome